Better Context → Better Decisions
Context counts in life sciences. The FENIX analyst team is tirelessly using its experience to put you in a position to succeed. Below, our readers with corporate access will find a wealth of contextualized life science insight ready to be viewed in the FENIX Marketplace.
Welcome to FENIX Syndicated Services. If you already have an account, please log in. If you have any questions or would like to subscribe to our services, please contact us.
$599
Posted in: Bolus Insulin, GLP-1RA, SGLT2i Oct 12 | 2020DAPA-HF CHMP Opinion This Week?; October 12-15 CHMP AgendaPurchase Blast
$599
Posted in: Other, SGLT2i Oct 09 | 2020First Results for Bayer's FIDELIO @ Kidney Week; ASN High-impact Trials ReleasedPurchase Blast
$599
Posted in: GLP-1RA, Insulin Delivery Oct 09 | 2020Novo Launches the First Rybelsus Video DTC campaign; New Omnipod DTC from InsuletPurchase Blast
$599
Posted in: Glucose Monitoring, Insulin Delivery, Other Oct 08 | 2020Livongo Partners with Fresenius for CKD; New CGM/AID Hospital GuidelinesPurchase Blast
$599
Posted in: Other Oct 08 | 2020GALACTIC-HF Results Disappoint; Omecamtiv Approval, but Utility is QuestionablePurchase Blast
$599
Posted in: Bolus Insulin, Glucose Monitoring, Insulin Delivery, Other Oct 07 | 2020Lilly and Dexcom Partner to Promote Lyumjev and G6 CGM; Omar Ishrak to Retire from Medtronic; Patia BioPharma and Precision Diabetes Partner for Diabetes Diagnostics; Capillary Bio Receives $1.5M Loan from HelmsleyPurchase Blast
$599
Posted in: Other, SGLT2i Oct 06 | 2020Sotagliflozin, Finerenone, and Omecamtiv CVOTs @ AHA 2020Purchase Blast
$599
Posted in: Basal Insulin, Bolus Insulin, Glucose Monitoring, SGLT2i Oct 05 | 2020Senseonics Files 180-Day Implantable CGM sPMA; Beyond Type 1 Launches Insulin Affordability Resource; KDIGO Releases New 2020 T2DM+CKD GuidelinesPurchase Blast
$599
Posted in: SGLT2i Oct 02 | 2020Farxiga Receives Breakthrough Therapy Designation for CKDPurchase Blast
$599
Posted in: Allogeneic, BCMA, CAR-T, CD19 Oct 02 | 2020Precision Biosciences Highlights First Patient Dosed with BCMA CAR-T PBCAR269A; PBCAR0191 Clinical Updates Delayed to YE; Q2 2020 Earnings SummaryPurchase Blast
$599
Posted in: Other Oct 01 | 2020Provention Bio Launches T1DM Screening Awareness CampaignPurchase Blast$599
Posted in: Other Sep 30 | 2020Provention Bio Files Teplizumab Clinical Module; ADA 2021 PDUFA Possible?Purchase Blast
$599
Posted in: Autologous, BCMA, CAR-T Sep 30 | 2020Legend Biotech Highlights FDA Filing of Cilta-Cel by YE 2020; Q2 2020 Earnings SummaryPurchase Blast
$599
Posted in: Other Sep 30 | 2020DreaMed Partners with Four Additional US Health ClinicsPurchase Blast
$599
Posted in: Glucose Monitoring, Other, SGLT2i Sep 29 | 2020Dexcom Publishes G6 UK Cost-Effectiveness Data and Launches G6 in Turkey; Lifescan Launches OneTouch Amazon Storefront; Daewoong Pharma Announces Ph2 Results for Enavogliflozin; Zucara Therapeutics Doses First Patient in Preventative Hypo StudyPurchase Blast
$599
Posted in: GLP-1RA, SGLT2i Sep 25 | 2020New Semaglutide HFpEF Trial (STEP HFpEF); DAPA-MI Posted on CT.gov; Final Day of EASD 2020 (Sept 25)Purchase Blast$599
Posted in: Glucose Monitoring, Insulin Delivery, Other Sep 24 | 2020Dexcom Partners with UVA, Novo CVD Real-world Treatment Study, Movano Partners for Smartwatch CGM; Imeglimin Ph3 Data; EASD 2020 Key Press Releases (Sept 24)Purchase Blast
$599
Posted in: GLP-1RA, Other Sep 23 | 2020FDA Launches Digital Health Center of Excellence; Novo Initiates New Ozempic and Rybelsus Trials; vTv Presents TTP399 Data; EASD 2020 Key Press Releases (Sept 23)Purchase Blast
$599
Posted in: Autologous, BCMA Sep 22 | 2020BMS and bluebird bio Receive Priority Review for Ide-cel; PDUFA Projected Around March 27, 2021Purchase Blast